\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
ProgrammesThe updated version of the Horizon Europe Work Programme (HE WP) 2026-2027 General Annexes was published on 29 September 2026 (available here). This article provides the changes compared to the previous version (1.0 with publication date 11 December 2025, available here), mainly focused on the participation of Chinese entitities.
Participation of China
The 2025 version of the General Annexes of the Work Programme, explicitly identified the limited areas where Chinese entities remain eligible in Research and Innovation Actions (RIAs). In this updated version, the destination "Transformative change towards a nature-positive economy and society" part of the Bridging Actions of the Horizontal Activities Work Programme has been added to this list.
From 4 to 10 critical technology areas on Chinese-controlled entities (p. 15)
The scope of the restriction on Chinese-controlled entities in Innovation Actions has been expanded from 4 to 10 critical technology areas.
The December 2025 version referred specifically to four areas:
In the updated General Annexes the following six areas have been added to this list:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.
